RecruitingPhase 2NCT07288034
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Sponsor: City of Hope Medical Center
Newnan, GA · +12 more sites